Chinese Pla General Hospital
Clinical trials sponsored by Chinese Pla General Hospital, explained in plain language.
-
Breakthrough drug combo aims to slash Leukemia's return after transplant
Disease control Recruiting nowThis study is testing whether adding two drugs, ruxolitinib and decitabine, to the standard pre-transplant treatment can better prevent leukemia from coming back in high-risk AML patients. It will compare this new combination against the usual treatments in 200 patients who have …
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test drug combo to boost lymphoma treatment power
Disease control Recruiting nowThis study is testing whether adding an oral drug called Eliglustat makes existing CD30-targeted immunotherapies work better against CD30-positive lymphoma. It will enroll about 40 adults who have had at least one prior treatment. Researchers want to see if this combination is sa…
Phase: PHASE1, PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test 'Off-the-Shelf' cell therapy that may outlast cancer
Disease control Recruiting nowThis study is testing a new type of cell therapy for adults whose B-cell acute lymphoblastic leukemia has come back or hasn't responded to standard treatments. Doctors take immune cells from healthy donors, genetically modify them to better target and fight leukemia cells, and in…
Phase: PHASE1, PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New drug combo tested to halt debilitating neurological attacks
Disease control Recruiting nowThis study aims to see if adding the drug eculizumab to standard steroid treatment is better at controlling sudden, severe attacks in people with neuromyelitis optica spectrum disorder (NMOSD). It will enroll 200 Chinese patients who are having an acute attack affecting their vis…
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Experimental cell therapy aims to tame rebellious immune system in chronic disease
Disease control Recruiting nowThis study is testing a new cell therapy for adults with IgG4-related disease, a chronic condition where the immune system attacks the body's own tissues. The therapy involves collecting a patient's own immune cells, modifying them in a lab to better target the disease, and then …
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New drug combo tested for advanced colon cancer
Disease control Recruiting nowThis study is testing whether giving two chemotherapy drugs together works better than standard treatments for advanced colorectal cancer. Researchers will enroll 583 adults with newly diagnosed, advanced disease who haven't had previous treatment. The main goal is to see if this…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New cell therapy trial offers hope for Tough-to-Treat stomach cancer
Disease control Recruiting nowThis study is testing whether a new cell therapy called RAK, made from umbilical cord blood, can help control advanced stomach cancer that has stopped responding to standard treatments. Researchers will compare the therapy against a control group in 90 patients to see if it exten…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Stem cell shot aims to rescue failing kidneys
Disease control Recruiting nowThis study is testing whether stem cells from umbilical cords can help treat sudden kidney failure, known as acute kidney injury. Researchers will give the cells to 50 patients to see if they improve kidney function and reduce the need for dialysis. The main goal is to check if t…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New hope for hodgkin lymphoma patients out of transplant options
Disease control Recruiting nowThis study is for adults with classical Hodgkin lymphoma that has returned or not responded to prior treatment, and who cannot or choose not to have a stem cell transplant. It will compare two different combination drug therapies to see which one better controls the cancer and ke…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Precision heat vapor zaps enlarged prostate in new trial
Disease control Recruiting nowThis study is testing a new, precise procedure that uses heat vapor to shrink enlarged prostate tissue. Doctors guide the treatment using combined MRI and ultrasound imaging to target the problem area accurately. The research aims to see if this approach safely improves urinary s…
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for dialysis patients battling anemia
Disease control Recruiting nowThis study is testing a new drug called pegmolesatide for treating anemia in people who need dialysis and whose current anemia treatment isn't working well enough. It will involve 240 participants across multiple hospitals in China who will be followed for 24 weeks. The main goal…
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Stem cell shot tested to halt kidney damage in diabetes
Disease control Recruiting nowThis study is testing whether an experimental treatment using umbilical cord stem cells (called Amimestrocel) can help slow or improve kidney damage in people with diabetic kidney disease. It will involve about 120 participants to see if the treatment is safe and if it can reduce…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for Tough-to-Treat colon cancer: 3-Drug combo enters trial
Disease control Recruiting nowThis study is testing new drug combinations for people with advanced colorectal cancer that has stopped responding to standard treatments. It will compare three different treatment groups to see if adding a repurposed drug called eliglustat to existing cancer therapies can help c…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Stick-On ultrasound patch aims to spot blood clots before they strike
Diagnosis Recruiting nowThis study is testing a new wearable ultrasound sensor designed to help doctors monitor certain conditions in real time. It will be tested on 300 adults with specific conditions like heart failure, deep vein thrombosis (a type of blood clot), or those in intensive care. The main …
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Smart hydration system aims to prevent kidney damage in elderly heart patients
Prevention Recruiting nowThis study tests whether personalized fluid therapy guided by lung water monitoring can prevent kidney damage in elderly patients with existing kidney problems who undergo coronary angiography. Researchers will compare two groups: one receiving standard care and one receiving flu…
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Prevention
Last updated Mar 30, 2026 14:34 UTC
-
Breathing breakthrough? rehab may help ICU patients on oxygen get stronger, go home sooner
Symptom relief Recruiting nowThis study is testing whether adding a special lung rehabilitation program helps patients in the intensive care unit (ICU) who are on high-flow oxygen therapy. Researchers will compare 70 patients who receive the rehab exercises to those who get standard medical care alone. They …
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
New breathing therapy aims to help ICU patients cough better
Symptom relief Recruiting nowThis study is testing whether a special breathing therapy called OLE can help ICU patients with pneumonia cough up mucus more effectively. Researchers will use a special imaging technique to see how well the therapy works in 62 adult patients. The main goal is to measure if patie…
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Can a common anesthesia drug stop Post-Surgery confusion in the elderly?
Symptom relief Recruiting nowThis study is testing if giving a small dose of a sedative called midazolam during the start of anesthesia helps prevent confusion and anxiety in older adults after surgery. Researchers will compare the drug to a placebo in over 600 patients aged 65-85. The main goal is to see if…
Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Massive study maps Men's bladder troubles across china
Knowledge-focused Recruiting nowThis is a large survey to understand how common and bothersome urinary symptoms are among men in China. Researchers will recruit over 12,500 men aged 40 and older from across the country to fill out questionnaires and have basic medical checks. The goal is to map out the problem,…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC